E. Ösby

413 total citations
20 papers, 272 citations indexed

About

E. Ösby is a scholar working on Pathology and Forensic Medicine, Hematology and Molecular Biology. According to data from OpenAlex, E. Ösby has authored 20 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 7 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in E. Ösby's work include Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Peripheral Neuropathies and Disorders (3 papers). E. Ösby is often cited by papers focused on Lymphoma Diagnosis and Treatment (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Peripheral Neuropathies and Disorders (3 papers). E. Ösby collaborates with scholars based in Sweden, Denmark and Russia. E. Ösby's co-authors include Magnus Björkholm, Åke Sidén, Francesca Chiodi, K.G. Kjellin, Robert Hast, E. Knutsson, Å Sidén, Ann Kari Lefvert, Anders Österborg and G. Holm and has published in prestigious journals such as Annals of Oncology, Cancer Letters and British Journal of Haematology.

In The Last Decade

E. Ösby

20 papers receiving 265 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Ösby Sweden 9 86 83 72 62 57 20 272
S. Schuster United States 6 50 0.6× 124 1.5× 41 0.6× 123 2.0× 199 3.5× 11 330
Robert B. Nussenblatt United States 9 234 2.7× 197 2.4× 59 0.8× 51 0.8× 110 1.9× 14 599
W Knapp Austria 11 20 0.2× 54 0.7× 126 1.8× 205 3.3× 53 0.9× 21 407
Matthew L. Ulrickson United States 8 47 0.5× 156 1.9× 77 1.1× 65 1.0× 313 5.5× 35 401
Matthias Mulazzani Germany 9 75 0.9× 111 1.3× 56 0.8× 184 3.0× 178 3.1× 11 393
Emmanuelle Bonnin France 7 51 0.6× 65 0.8× 85 1.2× 257 4.1× 15 0.3× 10 477
Judith Kinley United States 6 41 0.5× 71 0.9× 72 1.0× 40 0.6× 141 2.5× 7 291
Hema Dave United States 9 20 0.2× 28 0.3× 72 1.0× 56 0.9× 150 2.6× 27 241
Abhishek Saxena Netherlands 8 183 2.1× 22 0.3× 120 1.7× 109 1.8× 86 1.5× 12 452
Kenneth J. Caldwell United States 9 36 0.4× 18 0.2× 103 1.4× 83 1.3× 185 3.2× 21 335

Countries citing papers authored by E. Ösby

Since Specialization
Citations

This map shows the geographic impact of E. Ösby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Ösby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Ösby more than expected).

Fields of papers citing papers by E. Ösby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Ösby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Ösby. The network helps show where E. Ösby may publish in the future.

Co-authorship network of co-authors of E. Ösby

This figure shows the co-authorship network connecting the top 25 collaborators of E. Ösby. A scholar is included among the top collaborators of E. Ösby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Ösby. E. Ösby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Björkholm, Magnus, et al.. (2008). CNOP (mitoxantrone) chemotherapy is inferior to CHOP (doxorubicin) in the treatment of patients with aggressive non‐Hodgkin lymphoma (meta‐analysis). European Journal Of Haematology. 80(6). 477–482. 9 indexed citations
2.
Björkholm, Magnus, Hans Hagberg, Harald Holte, et al.. (2007). Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up. Annals of Oncology. 18(6). 1085–1089. 39 indexed citations
3.
Ösby, E., Johan Askling, Ola Landgren, et al.. (2004). Parental longevity and prognosis in elderly patients with aggressive non-hodgkin's lymphoma. Acta Oncologica. 43(3). 297–301. 6 indexed citations
4.
Ösby, E., Magnus Björkholm, Joachim Lundahl, & Jan Forslid. (2002). Granulocyte function in elderly patients receiving chemotherapy for aggressive non-Hodgkin’s lymphoma. European Journal of Internal Medicine. 13(7). 448–454. 4 indexed citations
5.
6.
Landgren, Ola, Johan Askling, Paul W. Dickman, et al.. (2002). Parental longevity and survival in elderly patients with Hodgkin's lymphoma.. PubMed. 87(6). 596–601. 6 indexed citations
7.
Sundblad, Anne, Anna Porwit, Inger Nennesmo, et al.. (2001). Antibody reactivities to skeletal muscle proteins in a patient with λ light chain secreting multiple myeloma, generalised amyloidosis and rhabdomyolysis. European Journal Of Haematology. 67(3). 189–193. 7 indexed citations
8.
Björkholm, Magnus, E. Ösby, Adam Taube, Eva Cavallin‐Ståhl, & Hans Hagberg. (2001). Reproducibility of Tumor Response Evaluation in Patients with High-Grade Malignant non-Hodgkin's Lymphoma. Medical Oncology. 18(2). 137–140. 4 indexed citations
9.
Björkholm, Magnus, et al.. (2001). Oral Etoposide in Patients with Hematological Malignancies. Medical Oncology. 18(4). 269–276. 12 indexed citations
10.
Celsing, Fredrik, Susanne Widell, K. Merk, et al.. (1998). Addition of etoposide to CHOP chemotherapy in untreated patients with high-grade non-Hodgkin’s lymphoma. Annals of Oncology. 9(11). 1213–1217. 9 indexed citations
11.
Söderhäll, Stefan, Astrid Gruber, E. Ösby, et al.. (1996). Higher in vivo protein binding of etoposide in children compared with adult cancer patients. Cancer Letters. 106(1). 97–100. 4 indexed citations
12.
Bergenbrant, Susanne, Qing Yi, E. Ösby, et al.. (1994). Anti‐Idiotypic B Lymphocytes in Patients with Monoclonal Gammopathies. Scandinavian Journal of Immunology. 40(2). 216–220. 12 indexed citations
13.
Yi, Qing, Susanne Bergenbrant, Anders Österborg, et al.. (1993). T‐Cell Stimulation Induced by Idiotypes on Monoclonal Immunoglobulins in Patients with Monoclonal Gammopathies. Scandinavian Journal of Immunology. 38(6). 529–534. 37 indexed citations
14.
Merk, K., Bo Johansson, Eva Kimby, et al.. (1991). Mitoxantrone, etoposide, cytarabine and prednisone as salvage therapy for refractory non‐Hodgkin lymphoma (NHL) and alternated with CHOP in previously untreated patients with NHL. European Journal Of Haematology. 46(1). 33–37. 8 indexed citations
15.
Ösby, E. & Peter Reizenstein. (1989). Quality of life and care in leukemia, myeloma and non-malignant disease. Opinions of patients and relatives, and effects of geography and time. Medical Oncology and Tumor Pharmacotherapy. 6(2). 133–141. 4 indexed citations
16.
Gruber, Astrid & E. Ösby. (1987). Osteolytic lesions in idiopathic myelofibrosis. Medical Oncology and Tumor Pharmacotherapy. 4(2). 107–109. 2 indexed citations
17.
Chiodi, Francesca, Åke Sidén, & E. Ösby. (1985). Isoelectric focusing of monoclonal immunoglobulin G, A and M followed by detection with the avidin‐biotin system. Electrophoresis. 6(3). 124–128. 37 indexed citations
18.
Ösby, E., et al.. (1982). Peripheral neuropathy in patients with benign monoclonal gammopathy — A pilot study. Journal of Neurology. 228(3). 185–194. 4 indexed citations
19.
Ösby, E., et al.. (1982). Benign monoclonal gammopathy and peripheral neuropathy. British Journal of Haematology. 51(4). 531–539. 37 indexed citations
20.
Ösby, E., et al.. (1978). Staging of Myeloma. A Preliminary Study of Staging Factors and Treatment in Different Stages. Recent results in cancer research. 65. 21–27. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Schuster Breakdown of academic impact, for papers by Robert B. Nussenblatt Breakdown of academic impact, for papers by W Knapp Breakdown of academic impact, for papers by Matthew L. Ulrickson Breakdown of academic impact, for papers by Matthias Mulazzani Breakdown of academic impact, for papers by Emmanuelle Bonnin Breakdown of academic impact, for papers by Judith Kinley Breakdown of academic impact, for papers by Hema Dave Breakdown of academic impact, for papers by Abhishek Saxena Breakdown of academic impact, for papers by Kenneth J. Caldwell
Rankless by CCL
2026